Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 5,634 | 6,322 | 14,079 | 9,166 | 5,648 |
| Cost of Goods | 3,154 | 3,384 | 4,244 | 4,564 | 4,151 |
| Gross Profit | 2,480 | 2,938 | 9,835 | 4,602 | 1,497 |
| Operating Expenses | 30,633 | 19,385 | 19,740 | 18,061 | 14,832 |
| Operating Income | -27,999 | -16,063 | -9,661 | -12,895 | -13,184 |
| Interest Expense | 137 | 177 | 126 | 241 | 168 |
| Other Income | 1,598 | 14,150 | 504 | 133 | 2,145 |
| Pre-tax Income | -26,538 | -2,090 | -9,283 | -13,003 | -11,207 |
| Net Income Continuous | -26,538 | -2,090 | -9,283 | -13,003 | -11,207 |
| Net Income | $-26,538 | $-2,090 | $-9,283 | $-13,003 | $-11,207 |
| EPS Basic Total Ops | -1.80 | -0.15 | -0.64 | -0.91 | -0.75 |
| EPS Basic Continuous Ops | -1.80 | -0.15 | -0.64 | -0.91 | -0.75 |
| EPS Diluted Total Ops | -1.80 | -0.15 | -0.64 | -0.91 | -0.75 |
| EPS Diluted Continuous Ops | -1.80 | -0.15 | -0.64 | -0.91 | -0.75 |
| EBITDA(a) | $-26,275 | $-15,239 | $-10,050 | $-11,691 | $-12,000 |